Cannapharm Technologies Malta Limited (“CPTM” or the “Company”) was represented at CannX 2018, the 3rd International Medical Cannabis Conference in Tel Aviv – Israel.
“CannX is a leading forum for the fast-growing Medical Cannabis (MC) industry” said Bruce H. Gaston, Director of CPTM. “Israel has been at the forefront of research and development in the MC sector and meeting with eminent pioneers in the field, such as Professor Raphael Mechoulan, is an opportunity that could not be missed ”.
CPTM representatives visited growing and manufacturing facilities and met with leading Israeli manufacturers of MC-based products and derivatives. Various protocols were agreed on future cooperation for the development of manufacturing and distribution services in Malta, in line with EU GMP standards.
Bruce H. Gaston
Cannapharm Technologies Malta Limited (CPTM) is a limited company, registered under the Companies Act, 1995 of the Republic of Malta.
CPTM believes in long-term, incremental growth, based on the latest technological advances. It works closely with governments, regulatory authorities and local municipalities, to utilise, integrate and grow existing local infrastructures, within the framework of regional and governmental development programs and targets.
As an EU-based enterprise, CPTM adheres to and implements the strictest of standards in its productions, whilst maintaining a result-driven, qualitative approach to its pharmaceutical operations in Europe and Asia.